Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,166.00    -34.00 (-2.83%)
Bid:
1,166.00
Ask:
1,168.00
Spread: 2.00 (0.172%)
Market Cap: £810.87m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisition

16 Nov 2010 07:00

RNS Number : 2224W
CVS Group plc
16 November 2010
 



Tuesday 16th November 2010

CVS Group plc ("CVS" or the "Company")

Acquisition

CVS Group plc

 

 

Acquisition of St David's Veterinary Hospital

 

CVS, one of the UK's leading providers of veterinary services, is pleased to announce the acquisition of St David's Veterinary Hospital (SDVH). SDVH is the centre of the small animal part of the St David's Veterinary group, one of the longest established and largest veterinary groups in the UK. It split into different speciality groups many years ago and the Small Animal Hospital is renowned throughout the South West as a leading centre for orthopaedic surgery. Peter Attenburrow will remain in charge of the business and will concentrate on his orthopaedic skills, with CVS providing full managerial support. This should result in improved capacity and services to the many referring practices that send cases to St David's for treatment.

The acquisition brings the total number of surgeries acquired to date in 2010 to 45 including a laboratory and a referral centre.

In total the group now operates 214 surgeries, 6 diagnostic labs, 1 pet crematorium and an online dispensary across the UK and remains the largest operator in a highly fragmented market.

The acquisition of SDVH is deemed to be a substantial transaction under the AIM Rules.

In the year ended 31 July 2009, SDVH achieved profit before tax of approximately £430,000 on turnover of approximately £1,858,000. The Company is acquiring the trade and assets of both St David's Veterinary Group and St David's Veterinary Clinic Limited and includes fixed assets of approximately £122,000 as at 31 July 2009. The consideration for the acquisition is £1,900,000 which includes £300,000 of deferred consideration but excludes payment in respect of stock and is being met entirely from existing cash resources. The practice employs 7 professional vets and 28 staff in total.

Commenting on the acquisition, CVS Chief Executive Simon Innes said: "SDVH is a long established business and we are delighted to be continuing to add to our portfolio following our acquisitions earlier in the year. We look forward to working with the team at St David's to help continue the high level of animal care and customer service that they have been delivering to date."

For further enquiries please contact:

 

CVS Group plc

 

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

 

 

Brewin Dolphin

 

Matt Davis

0845 213 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFEDLTLELII
Date   Source Headline
4th Oct 20187:00 amRNSExercise of Options and Total Voting Rights
27th Sep 20187:00 amRNSPreliminary Results
21st Sep 20184:21 pmRNSHolding(s) in Company
21st Sep 20184:21 pmRNSHolding(s) in Company
24th Aug 201812:22 pmRNSHolding(s) in Company
23rd Aug 20182:56 pmRNSHolding(s) in Company
21st Aug 20184:22 pmRNSHolding(s) in Company
21st Aug 20183:32 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSTrading Statement & Board Update
31st Jul 20185:45 pmRNSExercise of Options and Total Voting Rights
20th Jul 20187:00 amRNSBoard Changes and Notice of Trading Update
10th Jul 201810:35 amRNSHolding(s) in Company
6th Jul 20185:11 pmRNSHolding(s) in Company
2nd Jul 20184:51 pmRNSDirector/PDMR Shareholding
2nd Jul 20184:46 pmRNSTotal Voting Rights
2nd Jul 20183:05 pmRNSHolding(s) in Company
19th Jun 20187:00 amRNSBlock listing Interim Review
7th Jun 20184:18 pmRNSHolding(s) in Company
31st May 20183:40 pmRNSExercise of Options and Total Voting Rights
22nd May 20182:47 pmRNSHolding(s) in Company
18th May 20184:33 pmRNSHolding(s) in Company
10th May 20182:33 pmRNSHolding(s) in Company
4th May 20185:31 pmRNSHolding(s) in Company
30th Apr 20184:47 pmRNSTotal Voting Rights
24th Apr 20183:13 pmRNSHolding(s) in Company
23rd Apr 20185:55 pmRNSHolding(s) in Company
10th Apr 20182:26 pmRNSExercise of Options & TVR
4th Apr 201812:05 pmRNSDirector/PDMR and PCA Shareholding
3rd Apr 20188:20 amRNSHolding(s) in Company
29th Mar 20187:00 amRNSTotal Voting Rights
28th Mar 20184:42 pmRNSExercise of Options, Director/PCA Dealing & TVR
20th Mar 20183:06 pmRNSExercise of Options, Directors' dealings and TVR
1st Mar 20183:30 pmRNSTotal Voting Rights
21st Feb 20184:17 pmRNSHolding(s) in Company
16th Feb 20185:36 pmRNSResult of Placing
16th Feb 201812:45 pmRNSPlacing Update
16th Feb 201811:05 amRNSClose of Accelerated Bookbuild
16th Feb 20187:01 amRNSProposed Accelerated Bookbuild
16th Feb 20187:00 amRNSInterim Results
15th Feb 20187:00 amRNSExercise of Options & TVR
1st Feb 20183:43 pmRNSHolding(s) in Company
31st Jan 20182:21 pmRNSTotal Voting Rights
24th Jan 20185:40 pmRNSHolding(s) in Company
22nd Jan 20184:10 pmRNSHolding(s) in Company
22nd Jan 20184:03 pmRNSHolding(s) in Company
19th Jan 201812:30 pmRNSLong Term Incentive Plan Awards
18th Jan 20187:00 amRNSTrading Statement
17th Jan 20185:15 pmRNSTrading Statement
15th Jan 20182:55 pmRNSExercise of Options & TVR
11th Jan 20189:48 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.